Associate Research Scientist,
National Center For Natural Products Research
Research Institute
of Pharmaceutical sciences,
School of Pharmacy,
Mississippi, 38677,
USA
Mail to: prembala@olemiss.edu
Phone:
662-915-3463
Fax: 662-915-7062
Also visit me at:
UM School of Pharmacy web page
1994-1999 |
Ph.D in Medical Biochemistry from Department of Medical Biochemistry University of Madras, India. |
1991-1993 |
M.Sc. in Medical
Biochemistry from Department of Medical Biochemistry, University of Madras,
India |
1988-1991 |
B.Sc. Chemistry, University of Madras, India |
1994-
1997 |
Junior Research Fellow (University Grants
Commission, India) at
Department of Medical Biochemistry, University of Madras,
India. |
1998 |
Research Associate, Department of Biotechnology (R&D),
Tamilnad Hospital Academic Trust, Chennai (Affiliated to University of
Madras), India |
1999 -
2000 |
Senior Research Fellow, Department of
Animal Biotechnology, Madras Veterinary College, Tamilnadu Veterinary
and Animal Sciences University, Chennai, India. |
2000
-2002 |
Postdoctoral Fellow at University of
Nebraska Medical Center, Dept. of Biochemistry and
Molecular Biology, Omaha, Nebraska, USA. |
2002 -
2005 |
Postdoctoral Fellow at University
of Mississippi, National Center for Natural Products Research,
Research Institute of Pharmaceutical Sciences, School of Pharmacy,
Mississippi, USA. |
2005-till
date |
Associate Research Scientist at University
of Mississippi, National Center for Natural Products Research,
Research Institute of Pharmaceutical Sciences, School of Pharmacy,
Mississippi, USA. |
Bibliographical
Information
1. |
Balachandran, P and Govindarajan R. Ayurvedic Drug Discovery. Solicited review in
Expert Opinion on Drug Discovery (In Press). |
2. |
Balachandran, P (2007). Advancements of Ayurveda in Cancer
Management with Special Focus on Hepatocellular Carcinoma.- Solicited review
in Annals of Traditional Chinese medicine (In Press). |
3. |
Balachandran, P., Pugh
ND., Ma, G. and Pasco, DS (2006). Toll-like
receptor 2-dependent activation of monocytes by Spirulina polysaccharide and its immune enhancing action in
mice. Int. Immunopharmacol. 6, 1808-1814. |
4. |
Pawar, R., Balachandran, P., Pasco, DS and Khan, IA (2006). Cytotoxicity
studies of triterpenoids from Akebia trifoliata and Clematis ligustifolia. Acta Horticulturae, 720, 171-178. |
5. |
Premalatha Balachandran, Feng Wei, Rui-chao Lin, Ikhlas A.Khan, David S.
Pasco (2005). Structure-activity relationships of aristolochic acid
analogues. Toxicity in cultured
renal epithelial cells. Kidney international 67, 1797-1805. |
6. |
Nirmal Pugh, Premalatha Balachandran, Hemant Lata, Franck Dayan, Vaishali Joshi, Erdal
Bedir, Toshiaki Makino, Rita Mores, Ikhlas Khan, David Pasco (2005). Melanin:
Dietary mucosal immune modulators from Echinacea and other botanical
supplements. International Immunopharmacology 5, 637-647. |
7. |
Premalatha Balachandran and Rajgopal Govindarajan (2005). Cancer an
ayurvedic perspective - review. Pharmacological Research 51, 19-30. |
8. |
Rao, U.S., Baker, J.M. Pluznik,
J.L. and Premalatha Balachandran (2004). Role of intracellular Ca2+ in the
expression of amiloride-sensitive
sodium channel. Cell calcium 35, 21-28. |
9. |
Premalatha Balachandran and Rajgopal Govindarajan (2003). Hepatic disorders
in Scientific basis for
Ayurvedic Therapies,
L.C. Mishra (Ed.) CRC Press LLC, Florida, 231-254. |
10. |
Rao, U.S., Steimle, RE and Premalatha
Balachandran
(2003). Activation of large conductance
sodium channels upon expression of amiloride-sensitive sodium channel in Sf9
insect cells. Journal of Biological Chemistry, 277, 4900-4905. |
11. |
Premalatha, B. (2000) Semecarpus anacardium Linn. nuts - a boon in
alternative medicine - A review. Indian Journal of Experimental Biology,
38, 1177-1182. |
12. |
Premalatha, B. and Sachdanandam, P. (2000).
Potency of Semecarpus anacardium Linn. nut milk extract against aflatoxin B1
induced hepatocarcinogenesis: reflection on hepatic microsomal
biotransformation enzymes. Pharmacological Research, 42, 161 -166. |
13. |
Premalatha, B. and Sachdanandam, P. (2000).
Stabilization of lysosomal membrane and
glycoprotein content by Semecarpus anacardium nut extract in aflatoxin
B1 induced hepatocellular carcinoma. Phytotherapy Research, 14, 352 -355. |
14. |
Premalatha, B. and Sachdanandam, P.(2000).
Modulating role of Semecarpus anacardium Linn. nut milk extract on aflatoxin
B1 biotransformation. Pharmacological Research, 41,19-24. |
15. |
Premalatha, B. and Sachdanandam, P., (1999). Semecarpus anacardium Linn. nut extract
administration induces in vivo antioxidant defense system in aflatoxin B1 mediated
hepatocellular carcinoma. Journal of Ethnopharmacology, 66, 131-139. |
16. |
Navis Paul Sriganth, and Premalatha, B. (1999) Dietary curcumin with cisplatin administration modulates tumor marker
enzymes indices in experimental fibrosarcoma. Pharmacological Research, 39,175-179. |
17. |
Premalatha, B. and Sachdanandam, P. (1999).
Effect of Semecarpus anacardium Linn. nut extract against aflatoxin B1 induced
hepatocellular carcinoma. Fitoterapia, 70, 484-492. |
18. |
Premalatha, B. and Sachdanandam, P. (1999).
Modification of Semecarpus anacardium Linn. nut milk extract on Rat serum Alpha-fetoprotein level in aflatoxin B1 mediated
hepatic tumourigenesis. Fitoterapia, 70, 279-283. |
19. |
Premalatha, B. and Sachdanandam, P. (1999).
Alteration in lipid metabolism during the development of aflatoxin B1 induced
experimental hepatocellular carcinoma. Medical Science Research, 27, 779-782. |
20. |
Premalatha, B. (1999). Microsomal Membrane modulating efficacy
of Semecarpus anacardium Linn. Nut. Milk extract in experimental
hepatocellular carcinoma. Indian Drugs, 36, 714-719. |
21. |
Premalatha, B. and Sachdanandam, P. (1998).
Immunomodulatory activity of Semecarpus anacardium Linn. nut milk extract in
aflatoxin B1 induced hepatocellular carcinoma Pharmacy and Pharmacology
Communications, 4, 507-510. |
22. |
Premalatha, B. and Sachdanandam, P. (1998).
Regulation of mineral status by Semecarpus anacardium Linn. nut milk extract
in Aflatoxin B1 induced hepatocellular carcinoma. Journal of Clinical Biochemistry and Nutrition, 25, 63 -70. |
23. |
Premalatha, B.,
Muthulakshmi, V., Vijayalakshmi
T. and Sachdanandam, P.
(1999). Anticancer potency of
the milk extract of Semecarpus anacardium Linn. nuts against aflatoxin B1
mediated
Hepatocellular carcinoma bearing Wistar rats with reference to tumour
marker enzymes. Phytotherapy Research, 13, 183 - 187. |
24. |
Premalatha, B., Muthulakshmi, V.,
Vijayalakshmi T. and Sachdanandam, P. (1997).Semecarpus anacardium
nut extract induced changes in Enzymic antioxidants studied in aflatoxin B1
caused hepatocellular carcinoma bearing Wistar rats. Pharmaceutical Biology, 35,161-166. |
25. |
Premalatha, B., Sujatha V. and Sachdanandam, P. (1997). Modulating
effect of Semecarpus anacardium Linn. nut extract on glucose metabolizing
enzymes aflatoxin B1 induced experimental hepatocellular carcinoma. Pharmacological Research, 36, 187-192. |
26. |
Premalatha, B., Muthulakshmi, V.,
Vijayalakshmi T. and Sachdanandam, P. (1997). Protective role of Serankottai
Nei, a Siddha preparation, on cell membranes, in aflatoxin B1 induced
hepatocellular carcinoma bearing rats. Indian Drugs, 34, 385-389. |
27. |
Premalatha, B., Thangaraju, M. and Sachdanandam,
P. (1995). Influence of cyclophosphamide and vitamin E administration on the
rate of lipid peroxidation in experimental fibrosarcoma in rats. Journal
of Clinical Biochemistry and Nutrition, 18, 79-87. |
Research
during doctoral program: v Semecarpus anacardium nut extract v Widely used as an indigenous
drug by Indian Medical Practitioners for the treatment of various diseases especially
cancer and other inflammatory diseases. v But biochemical basis of its
anticancer activity was unknown. v Anticarcinogenic potency of Semecarpus
anacardium nut
milk extract was studied using hepatocellular carcinoma as a cancer model in
rats. v Extensive analysis was done to
study its effect against biochemical abnormalities during cancer. v The drug modulates the
abnormalities of all biochemical pathways including carbohydrate, lipid,
cytochrome P-450 mediated microsomal drug metabolism, cancer markers and membrane proteins during cancer
progression. v The dramatic reduction in
alpha-fetoprotein level, a specific marker of hepatocellular carcinoma was
observed on treatment. v Anticancer efficacy was further
confirmed by histopathological studies. v Our studies established the
therapeutic efficacy of Semecarpus anacardium nut extract on hepatocellular
carcinoma on solid grounds and have extensive potential to extend for
clinical applications. v Around 16 research articles
published from above work in reputed journals. v The information about the
structure, properties, clinical uses, and toxicity of Semecarpus
anacardium
nuts were compiled from the available literature since 1903 and published as
a review article. Research in
Molecular Biology during Post doctoral Programs: v Extremely rare bacterial
species called Bacteroides succinogenes
was isolated from cattle rumen fluid. v Cellulase gene from
cellulolytic bacteria was isolated and cloned into non cellulolytic
predominant rumen bacteria. v The clones were active in both in
vivo and in
vitro. v Biochemical aspects of
amiloride sensitive epithelial sodium channels (EnaC) and its role were
analyzed in pathophysiology of
cystic fibrosis and hypertension. v Functional abnormalities of
epithelial sodium channels expressed in Sf9 insect cells were tudied. v
Mammalian expression
vectors carrying cDNAs of EnaC fused with cDNAs of green fluorescent protein
were constructed and expressed in various mammalian cell lines to understand the
stability, trafficking and regulation of EnaC. |
Research at
National center for Natural Products center, University of Mississippi: v Various constituents of several of the popular
herbal supplements available in the current US market were determined and
standard measurements are developed as an estimate of the quality of these
herbal products. v The ingredients within an herbal supplement that is
responsible for accentuating the toxicity and diminishing the therapeutic
efficacy are identified. v Correlation of the structure-toxicity studies have
been evaluated. v Experiments are designed to eliminate toxic
principles from a health supplement so as to reduce the overall dose in
bringing the same amount efficacy. v New anti-inflammatory compound has been isolated and
its in vitro activities are being estimated. v Suitable animal models have
been developed to study in vivo immunostimulatory properties of active
constituents of herbal extracts and immune parameters are identified. v Pilot clinical trials have been
designed and conducted on Immune active preparations isolated in our
laboratory. v The parameters modulated by these herbal drugs are
identified and assays are being carried out for their quantitative
determination. |
v Serving in the reviewer panel
of Journal of Natural Products, Planta medica, Life Sciences, Expert Opinion
on Therapeutic Targets, Indian Journal of Experimental Biology etc. |
v Gold Medalist at undergraduate examination. |
v Recipient of Merit Certificate
from Royal Society of Chemistry (London). |
v Member of Society of Biological
Chemists (India). |
v Member of American Society of
Pharmacognosy. |
Research Experience
September, 2002 to till date National Center for Natural Products Research,
University of Mississippi Immunology: v
Designing and
performing clinical trials on immune stimulants and identifying parameters modulated by these immune
active substances. v
Developing animal
models (mice) to study immunostimulatory properties of herbs and their active
principles. v
Determination of
Immune Cells trafficking and identification and their quantification using
various antibodies by flow cytometry. v
Cytokine
quantification at protein level by ELISA and at mRNA level by RT-PCR. v
Immune Cell isolation
by enzymatic dissociation of various tissues from mouse and characterization. v
Isolation of
peripheral blood mononuclear cells and peritoneal cells and analysis of their
cytokine production. Inflammation:
v
Identification of
novel anti-inflammatory compounds from botanicals. v
Determination of mechanism
of their anti-inflammatory action. (e.g. NFkB inhibition) Cytotoxicity
and apoptosis: v
Whole cell viability
assays in mammalian cell lines. v
Screening of cytotoxic
and apoptotic activities from herbal compounds/extracts/products. v
Determination of structure
activity relationship of pure compounds isolated from herbal drugs. v
Purification of plant
materials by chromatographic techniques. v
Reporter gene assays. |
November, 2000 to April, 2002 Department of Biochemistry and Molecular Biology,
University of Nebraska Medical Center, Omaha, Nebraska, USA. v
Characterization of
amiloride sensitive sodium channels expressed in Sf9 insect cells. v
Channel properties
analysis by patch clamp techniques. v
Cloning and expression
of Sodium channel subunits in mammalian cell lines. v
Protein trafficking
analysis by using GFP tagged protein. v
Protein purification
by gel filtration and affinity chromatography techiniques. v
Protein separation and
identification by Polyacrylamide gel electrophoresis and western blotting. v
Determination of
protein stability and degradation pathway. |
May 1999- September 2000 Department
of Animal biotechnology, Madras Veterinary College, Chennai. v
Isolation of anaerobic
bacteria from rumen fluid. v
Isolation of
cellulolytic gene from cellulolytic bacteria. v
Cloning of
cellulolytic gene into noncellulolytic bacteria. |
1994-1998 Department
of Medical Biochemistry, University of Madras, Taramani campus, Chennai. v
Development of animal
models (rats) to study anticancer potential of Siddha drug. v
Assays on enzymes
involved in carbohydrate, protein, lipid metabolism. v
Isolation of liver
microsomes and enzyme activity determination of drug metabolizing enzymes. |
Clinical experiments: Designing of clinical
experiments, Dose and time response studies, Selection of suitable immune
modulating parameters, Isolation of peripheral blood mononuclear cells,
Total-, PMN-, Monocyte Phagocytosis by flow cytometry, Natural killer cell
cytotoxicity assay. Animal handling (Mice and rats): Maintenance, dose and time
response studies, monitoring animal behavior, food and water intake,
administration of drugs by various routes, fine tissue removal (e.g. Peyerıs
patches), collection of body fluids including peritoneal fluid, bone marrow
processing. Immunology: ELISA, immunocytochemistry,
flow cytometry, isolation of immune cells from various tissues by enzymatic
dissociation, PBMC isolation from human blood, immune cell identification by
antibody staining, quantification, determination of cellular trafficking. Molecular biology: Isolation of DNA, RNA, cloning
and mammalian cell transfection, protein expression in mammalian and insect
cells, protein purification by various chromatographical methods viz., size
exclusion, ion-exchange, affinity, PAGE, agarose gel electrophoresis, Western
blotting, RT-PCR, RNAse protection assay. Cell culture techniques: Mammalian and insect
cell maintenance and transfection using various methods, cell based assays
and multiplex assays for cytotoxicity and apoptosis, nuclear staining, gene
reporter assays. Biochemistry: General biochemical assays,
enzyme assays, isolation of microsomes and assessment of microsomal enzymes
activity. Microbiology: Isolation of rare bacteria,
maintenance, propagation. Radiolabeling: Making DNA probes and RNase
Protection assay. Statistics: Studentıs t test, Repeated measures t test (paired, unpaired,
one-tailed, two-tailed) |
Last revised date: 18th October 2007